Fidelity® Select Biotechnology Portfolio

Class No Load (FBIOX)
Scorecard
4 / 5 Stars
Lipper
5 5 3 5 4
Zacks Investment Research
1 (Strong Buy)
Standard & Poor's
5 / 5 Stars
TheStreet.com
A- (Buy)

Risk

The fund's Value Line Risk Rank, a measure of volatility, is 5 on a scale of 1 to 5, with 1 being the least volatile and 5 the most.

Value Line 2014-04-10

Volatility Measurements

Updated 03.31.2014

Standard Deviation 21.28
Mean 2.94
Sharpe Ratio 1.66
Bear Market Decile Rank 21

Modern Portfolio Theory Statistics

Updated 03.31.2014

Standard Index
MSCI ACWI NR USD
Best Fit Index
Morningstar SEC/Healthcare TR USD
R-Squared 27.94 62.54
Beta 0.77 1.44
Alpha 28.11 3.33

See Also:

Top Fidelity Investments Funds